Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Status:
Completed
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
An International Phase II, double-blind, randomized, placebo-controlled study to evaluate the
safety and efficacy of LAU-7b administered once-daily for 6 months for the treatment of CF.
Phase:
Phase 2
Details
Lead Sponsor:
Laurent Pharmaceuticals Inc.
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics